Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lissy de Ridder

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Alimentary Pharmacology & Therapeutics|October 5, 2024
Editorial: Distinct Challenges of Paediatric From Adult-Onset Inflammatory Bowel Disease, Implications of Aggressive Disease Phenotypes and Early Biologic Therapy in ChildrenAlessandro Molinaro, Lissy de Ridder
Journal of Pediatric Gastroenterology and Nutrition|June 29, 2017
New Kids in the Neighborhood: BiosimilarsLissy de Ridder, Harland Winter
Alimentary Pharmacology & Therapeutics|May 22, 2024
Editorial: Infliximab induction therapy in paediatric Crohn's disease - A cost-effective strategy? Authors' replyStephanie A Vuijk, Lissy de Ridder
Journal of Pediatric Gastroenterology and Nutrition|June 26, 2015
Infliximab More Effective in Therapy-Naïve Than in Therapy-Refractory PatientsMartinus Arend Cozijnsen, Lissy de Ridder
Alimentary Pharmacology & Therapeutics|February 14, 2023
Editorial: achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel diseaseStephanie A Vuijk, Lissy de Ridder
Journal of Pediatric Gastroenterology and Nutrition|May 21, 2021
Reply to "Re: Diagnosis, Management, and Prevention of Button Battery Ingestion in Childhood: an ESPGHAN Position Paper"Lissy de Ridder, Marc A Benninga
Alimentary Pharmacology & Therapeutics|November 10, 2022
Editorial: implications and future perspectives of the increase in biologics use in paediatric inflammatory bowel diseaseStephanie A Vuijk, Lissy de Ridder
Journal of Pediatric Gastroenterology and Nutrition|April 28, 2021
Reply to "Re: Diagnosis, Management, and Prevention of Button Battery Ingestion in Childhood: An ESPGHAN Position Paper"Lissy de Ridder, Marc A Benninga
The Lancet. Gastroenterology & Hepatology|December 10, 2022
Vedolizumab in paediatric IBD: a huge step forward but not there yetRenz C W Klomberg, Lissy de Ridder
Expert Review of Clinical Pharmacology|February 16, 2019
Cannabis, a potential treatment option in pediatric IBD? Still a long way to goNienke Halbmeijer, Michael Groeneweg, Lissy De Ridder
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Alimentary Pharmacology & Therapeutics|October 5, 2024
Editorial: Distinct Challenges of Paediatric From Adult-Onset Inflammatory Bowel Disease, Implications of Aggressive Disease Phenotypes and Early Biologic Therapy in ChildrenAlessandro Molinaro, Lissy de Ridder
Journal of Pediatric Gastroenterology and Nutrition|June 29, 2017
New Kids in the Neighborhood: BiosimilarsLissy de Ridder, Harland Winter
Alimentary Pharmacology & Therapeutics|May 22, 2024
Editorial: Infliximab induction therapy in paediatric Crohn's disease - A cost-effective strategy? Authors' replyStephanie A Vuijk, Lissy de Ridder
Journal of Pediatric Gastroenterology and Nutrition|June 26, 2015
Infliximab More Effective in Therapy-Naïve Than in Therapy-Refractory PatientsMartinus Arend Cozijnsen, Lissy de Ridder
Alimentary Pharmacology & Therapeutics|February 14, 2023
Editorial: achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel diseaseStephanie A Vuijk, Lissy de Ridder
Journal of Pediatric Gastroenterology and Nutrition|May 21, 2021
Reply to "Re: Diagnosis, Management, and Prevention of Button Battery Ingestion in Childhood: an ESPGHAN Position Paper"Lissy de Ridder, Marc A Benninga
Alimentary Pharmacology & Therapeutics|November 10, 2022
Editorial: implications and future perspectives of the increase in biologics use in paediatric inflammatory bowel diseaseStephanie A Vuijk, Lissy de Ridder
Journal of Pediatric Gastroenterology and Nutrition|April 28, 2021
Reply to "Re: Diagnosis, Management, and Prevention of Button Battery Ingestion in Childhood: An ESPGHAN Position Paper"Lissy de Ridder, Marc A Benninga
The Lancet. Gastroenterology & Hepatology|December 10, 2022
Vedolizumab in paediatric IBD: a huge step forward but not there yetRenz C W Klomberg, Lissy de Ridder
Expert Review of Clinical Pharmacology|February 16, 2019
Cannabis, a potential treatment option in pediatric IBD? Still a long way to goNienke Halbmeijer, Michael Groeneweg, Lissy De Ridder
Pageof 13